Form4insider filings, from the source

SEC Form 4 · accession 0000905718-19-000246

PLx Pharma Inc. · PLXP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Feb 20, 2019
Accepted (ET)
Feb 22, 2019 · 4:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001497504

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Convertible Preferred StockF1,F3,F2$2.60Feb 20, 2019P15,000AFeb 20, 2019—Common Stock5,769,23015,000I

Explanation of responses